Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

CureSearch for Children’s Cancer will award $2 million in funding to support a phase I clinical trial in 24 children and young adults with recurrent brain tumors.

September 06, 2024

Vol.50 No.33

In Brief

Cheng-Chia Wu joins Fralin Biomedical Research Institute at Virginia Tech Carilion

Cheng-Chia “Fred” Wu, a physician-scientist who treats brain tumors in children, has joined Virginia Tech to bring his expertise in focused ultrasound cancer research to the Fralin Biomedical Research Institute at Virginia Tech Carilion.

August 09, 2024

Vol.50 No.32

In Brief

NeOnc Technologies receives California Investment Forum’s Breakthrough Medical Technology Achievement Award

NeOnc Technologies Holdings Inc., a clinical-stage biopharmaceutical company, has received the Breakthrough Medical Technology Achievement Award from the California Investment Forum for its innovations in medical technology related to the treatment of brain and central nervous system diseases.

August 02, 2024

Vol.50 No.31

Clinical Roundup

AI system identifies genes that can convert brain cancer cells into functioning immune cells in mice

In an innovative new study of glioblastoma, scientists used artificial intelligence to reprogram cancer cells, converting them into dendritic cells, which can identify cancer cells and direct other immune cells to kill them.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Unexpected role of OTX2 drives aggressive medulloblastoma

Researchers at Baylor College of Medicine, Texas Children’s Hospital, the University of Manitoba, and collaborating institutions revealed an unexpected way in which the protein OTX2 drives the progression of medulloblastoma—the most common aggressive childhood brain cancer.

July 19, 2024

Vol.50 No.29

In Brief

Linda Liau elected to Taiwan’s Academia Sinica

Linda Liau, chair of neurosurgery at the David Geffen School of Medicine at UCLA, was elected as an Academician of Academia Sinica by the 35th Convocation of Academicians, the preeminent academic institution in Taiwan.

July 12, 2024

Vol.50 No.28

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

YOU MAY BE INTERESTED IN

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

Cheng-Chia Wu joins Fralin Biomedical Research Institute at Virginia Tech Carilion

NeOnc Technologies receives California Investment Forum’s Breakthrough Medical Technology Achievement Award

AI system identifies genes that can convert brain cancer cells into functioning immune cells in mice

Unexpected role of OTX2 drives aggressive medulloblastoma

Linda Liau elected to Taiwan’s Academia Sinica

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login